Effects of promyelocytic leukemia protein on virus-host balance

Journal of Virology

Volumn 76, Issue 8, 2002, Pages 3810-3818

  Bonilla, Weldy V ^a   Pinschewer, Daniel D ^a   Klenerman, Paul ^a   Rousson, Valentin ^a   Gaboli, Mirella ^a   Pandolfi, Pier P ^a   Zinkernagel, Rolf M ^a   Salvato, Maria S ^a   Hengartner, Hans ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NEUTRALIZING ANTIBODY; PROMYELOCYTIC LEUKEMIA PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DOSE RESPONSE; EDEMA; EMBRYO; FIBROBLAST; FOOT PAD; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOLOGY; IN VIVO STUDY; INFECTION SENSITIVITY; INOCULATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ARENAVIRIDAE INFECTIONS; CELLS, CULTURED; FIBROBLASTS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; NEOPLASM PROTEINS; NEUTRALIZATION TESTS; NUCLEAR PROTEINS; RHABDOVIRIDAE INFECTIONS; T-LYMPHOCYTES, CYTOTOXIC; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

EID: 0036200416     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.8.3810-3818.2002     Document Type: Article

References (77)

1. cDNA structures and regulation of two interferon-induced human Mx proteins
2. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
3. Immunization with recombinant protein: Conditions for cytotoxic T cell and/or anti-body induction
4. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction?
5. Induction of long-lived germinal centers associated with persisting antigen after viral infection
6. Neutralizing antiviral B cell responses
7. Requirement of cell nucleus for the replication of an arenavirus
8. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates
9. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm
10. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17
11. The virology and immunobiology of lymphocytic choriomeningitis virus infection
12. The lymphocytic choriomeningitis virus RING protein Z associates with eukaryotic initiation factor 4E and selectively represses translation in a RING-dependent manner
13. Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection
14. Induction of the PML protein by interferons in normal and APL cells
15. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
16. Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease
17. The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol
18. Short-duration exposure and the transmission of rhinoviral colds
19. PML protein expression in hematopoietic and acute promyelocytic leukemia cells
20. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus
21. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus
22. T-cell-mediated immunopathology in viral infections
23. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
24. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling
25. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains
26. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
27. + T-cell precursors on the outcome of virus infection
28. Cell cycle regulation of PML modification and ND10 composition
29. HSV-1 IE protein Vmw110 causes redistribution of PML
30. Characterization of a zinc finger gene disrupted by t(15;17) in acute promyetocytic leukemia
31. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
32. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
33. Viral clearance without destruction of infected cells during acute HBV infection
34. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors
35. Immunopathology of adoptive immunization in mice chronically infected with lymphocytic choriomeningitis virus
36. The biology of lymphocytic choriomeningitis infection: Virus induced immune disease
37. Persistent and slow virus infection
38. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
39. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins
40. Minimal infective dose of attenuated poliovirus for man
41. Disruption of PML-associated nuclear bodies during human cytomegalovirus infection
42. The PML growth-suppressor has an altered expression in human oncogenesis
43. The t(15;17) translocation alters a nuclear body in a RA-reversible fashion
44. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
45. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML
46. Lymphocytic choriomeningitis virus
47. Mechanism of recovery from acute virus infection. IV. Questionable role of mononuclear phagocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice
48. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML
49. Molecular determinants of macrophage tropism and viral persistence: Importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus
50. Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins
51. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon
52. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice
53. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
54. + T lymphocytes
55. PML, a growth suppressor disrupted in acute promyelocytic leukemia
56. Natural antibodies and complement link innate and acquired immunity
57. Vaccination for disease
58. Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections
59. A novel zinc finger coiled-coil domain in a family of nuclear proteins
60. Molecular basis of viral persistence: A single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence
61. Mechanism of interferon action: Phosphorylation of protein synthesis initiation factor elF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase
62. Mechanisms of the antiviral action of interferons
63. Interferon-induced Mx protein: A mediator of cellular resistance to influenza virus
64. PML shuttles between nuclear bodies and the cytoplasm
65. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
66. Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: Interference with early steps of viral replication
67. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
68. Role of PML in cell growth and the retinoic acid pathway
69. PML is essential for multiple apoptotic pathways
70. Human rotavirus studies in volunteers: Determination of infectious dose and serological response to infection
71. Immunofluorescent studies of the histopathogenesis of lymphocytic choriomeningitis virus infection
72. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
73. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARα and T18 oncoproteins
74. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness
75. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?
76. Antiviral immunity
77. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D